RANCHO CUCAMONGA, CA / ACCESS Newswire / December 15, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the U.S. Food and Drug Administration ("FDA") has approved the Company's Abbre ...
In December 2025, Amphastar Pharmaceuticals announced that the FDA approved its abbreviated new drug application for a teriparatide injection prefilled pen, deemed bioequivalent and therapeutically ...
Investing.com -- Amphastar Pharmaceuticals (NASDAQ:AMPH) stock gained 2.3% in Monday’s premarket trading after the company announced FDA approval of its teriparatide injection, a generic equivalent to ...
Floyd Petersen, director of Amphastar Pharmaceuticals ( AMPH 0.97%), exercised 16,679 options for common stock and immediately sold all resulting shares in a transaction valued at $441,836.72, as ...
Amphastar Pharmaceuticals faces flat growth and margin pressure as it shifts from generics to branded drugs. Learn why AMPH ...
The legal guardian of one of the Florida teens accused in the horrific slaying of 14-year-old Danika Troy was busted on drug charges within hours of the murder, which saw Troy lured into the woods, ...
Former Honduras President Juan Orlando Hernández was released from prison Monday after President Trump pardoned him of charges related to assisting drug traffickers. “After nearly four years of pain, ...
MSK Breast Medical Oncologist Sherry Shen, MD, is an expert in the relationship between obesity, diet, and cancer. Her research includes studying new weight loss drugs such as Zepbound, Wegovy, and ...
Stock futures inched higher in the premarket hours of Monday as traders entered the final full trading week before the Christmas holidays. Here are some of Monday's biggest stock movers: Biggest stock ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results